754 related articles for article (PubMed ID: 20389243)
1. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
Hughes RA
Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
[TBL] [Abstract][Full Text] [Related]
3. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
4. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
5. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
Rabie M; Nevo Y
Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
8. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update.
Nobile-Orazio E; Gallia F; Tuccillo F; Terenghi F
Curr Opin Neurol; 2010 Oct; 23(5):519-23. PubMed ID: 20689427
[TBL] [Abstract][Full Text] [Related]
10. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
12. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
14. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
Bright RJ; Wilkinson J; Coventry BJ
BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
[TBL] [Abstract][Full Text] [Related]
16. Immune mediated neuropathies--an update on therapeutic strategies.
Czaplinski A; Steck AJ
J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
[TBL] [Abstract][Full Text] [Related]
17. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Eftimov F; van Schaik I
Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Guimarães-Costa R; Iancu Ferfoglia R; Viala K; Léger JM
Rev Neurol (Paris); 2014 Oct; 170(10):595-601. PubMed ID: 25200479
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
